The fundraise is the firm’s largest to date, providing a lift for a European biotech industry that’s fallen further behind its counterparts in the U.S. and China.

GenScript Biotech Corporation today announced the GenScript and NVIDIA Life Sciences Startup PitchFest, a global competition ...

AI is rewriting biotech’s commercial playbook—cutting waste, shrinking teams, and giving first‑time drugmakers a faster, smarter path to launch. There are hundreds of biotechnology companies today ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — A group of European venture ...

Endpoints News, the biopharma industry’s source for breaking news, exclusive reporting and smart analysis, today unveiled ...

Anthropic has purchased the stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The Information and Eric Newcomer. Sources close to the deal confirmed to TechCrunch ...

Every year, thousands of biotech breakthroughs stall. Not because the science failed, but because the story did. A survey of biotech investors found that 86% believe that fewer than half of management ...

Promising South Korean biotech startups are using Japan as a springboard to break into global markets, showcasing new drug ...

AHMEDABAD: Gujarat is planning a Rs 100-crore investment over five years to establish the Marine Biotechnology Research & ...

The gene-editing company Beam Therapeutics is alleging that one of its scientists stole intellectual property and used it to ...

Guadalupe Hayes-Mota is director, bioethics at the Markkula Center for Applied Ethics. Views are his own. This article, "Using the CARES Framework to Build Ethical Biotech Startups" , originally ...

There are hundreds of biotechnology companies today that have never commercialized a drug. For many years, the standard approach in the industry has been to advance the science, prove the asset, and ...